Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,031 | 66,950 | 43,675 | 105,216 | 96,701 |
| Marketable Securities | 488,274 | 541,063 | 645,710 | 674,743 | 387,786 |
| Receivables | 13,230 | 10,625 | 9,126 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 0 | -1 |
| TOTAL | $578,560 | $634,986 | $707,865 | $794,581 | $505,267 |
| Non-Current Assets | |||||
| PPE Net | 17,659 | 14,518 | 11,295 | 11,865 | 12,530 |
| Other Non-Current Assets | 19,526 | 18,516 | 20,093 | 5,821 | 6,377 |
| TOTAL | $37,185 | $33,034 | $31,388 | $17,686 | $18,907 |
| Total Assets | $615,745 | $668,020 | $739,253 | $812,267 | $524,174 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 73,260 | 62,923 | 65,551 | 46,854 | 97,693 |
| TOTAL | $87,571 | $72,680 | $78,512 | $54,527 | $102,155 |
| Non-Current Liabilities | |||||
| Long Term Debt | 348,367 | 344,825 | 341,356 | 337,898 | N/A |
| Deferred Revenues | 6,836 | 6,019 | 5,694 | 3,935 | 4,462 |
| Other Non-Current Liabilities | 6,540 | 6,268 | 0 | 0 | 0 |
| TOTAL | $358,470 | $355,102 | $345,809 | $342,797 | $5,345 |
| Total Liabilities | $446,041 | $427,782 | $424,321 | $397,324 | $107,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,100 | 25,009 | 24,831 | 24,809 | 24,726 |
| Common Shares | 25 | 25 | 25 | 25 | 25 |
| Retained earnings | -1,285,670 | -1,199,106 | -1,108,460 | -988,418 | -899,603 |
| Other shareholders' equity | -1,529 | -2,182 | -2,801 | -2,924 | -1,160 |
| TOTAL | $169,704 | $240,238 | $314,932 | $414,943 | $416,674 |
| Total Liabilities And Equity | $615,745 | $668,020 | $739,253 | $812,267 | $524,174 |